Sarah E. Cabral, PharmD, BCOP, is a clinical pharmacist at Lifespan Specialty Pharmacy in Providence. She has spent the majority of her career serving the oncology patient population and currently specializes in thecare of patients with genitourinary cancer receiving oral anticancer therapy. REFERENCE...
Prostate cancer is one of the most commonly diagnosed cancers in men and is a major cause of cancer-related deaths worldwide. Among the molecular processes that contribute to this disease, the weight of metabolism has been placed under the limelight in r
Atorvastatin prolongs the lifespan of radiation induced reactive oxygen species in PC-3 prostate cancer cells to enhance the cell killing effect. Yu H,Sun SQ,Gu XB,et al. Oncology Reports . 2017Yu, Hao,Sun,etc.Atorvastatin prolongs the lifespan of radiation-induced reactive oxygen species in ...
Prostate cancer in the elderly. With the significant increase of the average lifespan in the industrial world, the number of elderly people, as a proportion of the total population, has r... KN Syrigos,E Karapanagiotou,KJ Harrington - 《Anticancer Research》 被引量: 79发表: 2005年 HISTOLOGY...
“Our findings show that high levels of bone turnover biomarkers are associated with a shorter lifespan in men newly diagnosed with metastatic HSPC,” said UC Davis Comprehensive Cancer Center Director Primo “Lucky” Lara Jr.“In the future, knowing one’s bone biomarker status could improve ho...
onc OPEN ORIGINAL ARTICLE Heat-shock factor 2 is a suppressor of prostate cancer invasion JK Björk1,2,4, M Åkerfelt1,2,4, J Joutsen1,3, MC Puustinen1,3, F Cheng1,3, L Sistonen1,3,4 and M Nees1,4 Heat-shock factors (HSFs) are key transcriptional regulators in cell survival...
Objectives: This study investigated the relationships between a mindfulness-based stress reduction meditation program for early stage breast and prostate cancer patients and quality of life, mood states, stress symptoms, and levels of cortisol, dehydroepiandrosterone-sulfate (DHEAS) and melatonin. Methods...
Currently, the most used therapy for hormone-naive PCa cancer patients is androgen depletion therapy (ADT). ADT could lead patients to an initially beneficial stage with tumor extinction, but eventually the majority of hormone-naive PCa become less sensitive to ADT and progress into a more ...
PBGD in particular was chosen for normalisation as studies found it to show little variation between PCa tissue of different stage and grade. Identification and extraction of cancerous tissue Tumour tissue was identified by a histopathologist and, to avoid inconsistency, the same histopathologist ...
Castration-resistant prostate cancer is an incurable and highly aggressive terminal stage of prostate cancer, seriously jeopardizing the patient’s quality of life and lifespan. The management of castration-resistant prostate cancer is complex and has opened new fields of research during the last ...